Dinglasa, Analine .
HRN: 09-66-45 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2022
CEFUROXIME 1.5GM (VIAL)
11/30/2022
11/30/2022
IVT
1.5gm
LD
For STAT CS
Waiting Final Action